Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 3, 2002, Pages 356-361

  Goss, Christopher H ^a   Otto, Kelly ^a   Aitken, Moira L ^a   Rubenfeld, Gordon D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Outcome; Stenotrophomonas maltophilia; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; COHORT ANALYSIS; COMORBIDITY; CONSULTATION; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGISTER; SCHOOL CHILD; SPUTUM ANALYSIS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL TIME;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPUTUM; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE; TIME FACTORS;

EID: 0036683366     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2109078     Document Type: Article

References (20)

1. The diagnosis of cystic fibrosis: A consensus statement
2. Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcome
3. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis
4. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
5. Infective endocarditis due to Stenotrophomonas (Xanthomonas) Maltophilia
6. Stenotrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: A study of 143 patients
7. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis
8. Bacterial colonisation with Xanthomonas maltophilia: A retrospective study in a cystic fibrosis patient population
9. Stenotrophomonas maltophilia in cystic fibrosis: Incidence and prevalence
10. The changing epidemiology of cystic fibrosis
11. Changes in the normal maximal expiratory flow-volume curve with growth and aging
12. The impact of confounder selection criteria on effect estimation
13. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis
14. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients
15. Microbiology of sputum from patients at cystic fibrosis centers in the United States
16. Stenotrophomonas maltophilia in cystic fibrosis patients
17. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis
18. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis